FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366988954> ?p ?o ?g. }

• W4366988954 endingPage "190" @default.
• W4366988954 startingPage "180" @default.
• W4366988954 abstract "Objective Safinamide is a selective, reversible monoamine oxidase B inhibitor with demonstrated efficacy and tolerability in placebo-controlled studies and is clinically useful for patients with motor fluctuations. This study evaluated the efficacy and safety of safinamide as a levodopa adjunct therapy in Asian patients with Parkinson’s disease.Methods Data from 173 Asian and 371 Caucasian patients from the international Phase III SETTLE study were included in this post hoc analysis. The safinamide dose was increased from 50 mg/day to 100 mg/day if no tolerability issues occurred at week 2. The primary outcome was the change from baseline to week 24 in daily ON-time without troublesome dyskinesia (i.e., ON-time). Key secondary outcomes included changes in Unified Parkinson’s Disease Rating Scale (UPDRS) scores.Results Safinamide significantly increased daily ON-time relative to placebo in both groups (least-squares mean: 0.83 hours, <i>p</i> = 0.011 [Asians]; 1.05 hours, <i>p</i> < 0.0001 [Caucasians]). Motor function relative to placebo (UPDRS Part III) improved significantly in Asians (-2.65 points, <i>p</i> = 0.012) but not Caucasians (-1.44 points, <i>p</i> = 0.0576). Safinamide did not worsen Dyskinesia Rating Scale scores in either subgroup, regardless of the presence or absence of dyskinesia at baseline. Dyskinesia was largely mild for Asians and moderate for Caucasians. None of the Asian patients experienced adverse events leading to treatment discontinuation.Conclusion Safinamide as a levodopa adjunct is well tolerated and effective in reducing motor fluctuations in both Asian and Caucasian patients. Further studies to investigate the real-world effectiveness and safety of safinamide in Asia are warranted." @default.
• W4366988954 created "2023-04-27" @default.
• W4366988954 creator A5000571986 @default.
• W4366988954 creator A5011173411 @default.
• W4366988954 creator A5023723137 @default.
• W4366988954 creator A5042106636 @default.
• W4366988954 creator A5042108099 @default.
• W4366988954 creator A5064700091 @default.
• W4366988954 creator A5068806174 @default.
• W4366988954 date "2023-05-31" @default.
• W4366988954 modified "2023-10-12" @default.
• W4366988954 title "Safinamide as an Adjunct to Levodopa in Asian and Caucasian Patients With Parkinson’s Disease and Motor Fluctuations: A Post Hoc Analysis of the SETTLE Study" @default.
• W4366988954 cites W1522426715 @default.
• W4366988954 cites W1547633323 @default.
• W4366988954 cites W1631523450 @default.
• W4366988954 cites W1952010211 @default.
• W4366988954 cites W1952703466 @default.
• W4366988954 cites W2034825135 @default.
• W4366988954 cites W2084487494 @default.
• W4366988954 cites W2098550556 @default.
• W4366988954 cites W2116294828 @default.
• W4366988954 cites W2122085123 @default.
• W4366988954 cites W2128364757 @default.
• W4366988954 cites W2135640360 @default.
• W4366988954 cites W2165137024 @default.
• W4366988954 cites W2171241738 @default.
• W4366988954 cites W2180191915 @default.
• W4366988954 cites W2563082987 @default.
• W4366988954 cites W2734467372 @default.
• W4366988954 cites W2745146377 @default.
• W4366988954 cites W2770294408 @default.
• W4366988954 cites W2770852789 @default.
• W4366988954 cites W2792548008 @default.
• W4366988954 cites W2804857825 @default.
• W4366988954 cites W2948460590 @default.
• W4366988954 cites W2983210386 @default.
• W4366988954 cites W2985525368 @default.
• W4366988954 cites W3013809120 @default.
• W4366988954 cites W3023737799 @default.
• W4366988954 cites W3033955876 @default.
• W4366988954 cites W3093084948 @default.
• W4366988954 cites W3165630967 @default.
• W4366988954 cites W3188679710 @default.
• W4366988954 cites W3204637719 @default.
• W4366988954 cites W4200183778 @default.
• W4366988954 cites W4200454990 @default.
• W4366988954 cites W4210721752 @default.
• W4366988954 cites W4281252749 @default.
• W4366988954 cites W4293216571 @default.
• W4366988954 cites W4308591063 @default.
• W4366988954 doi "https://doi.org/10.14802/jmd.22196" @default.
• W4366988954 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37096301" @default.
• W4366988954 hasPublicationYear "2023" @default.
• W4366988954 type Work @default.
• W4366988954 citedByCount "0" @default.
• W4366988954 crossrefType "journal-article" @default.
• W4366988954 hasAuthorship W4366988954A5000571986 @default.
• W4366988954 hasAuthorship W4366988954A5011173411 @default.
• W4366988954 hasAuthorship W4366988954A5023723137 @default.
• W4366988954 hasAuthorship W4366988954A5042106636 @default.
• W4366988954 hasAuthorship W4366988954A5042108099 @default.
• W4366988954 hasAuthorship W4366988954A5064700091 @default.
• W4366988954 hasAuthorship W4366988954A5068806174 @default.
• W4366988954 hasBestOaLocation W43669889541 @default.
• W4366988954 hasConcept C126322002 @default.
• W4366988954 hasConcept C142724271 @default.
• W4366988954 hasConcept C187960798 @default.
• W4366988954 hasConcept C197934379 @default.
• W4366988954 hasConcept C204787440 @default.
• W4366988954 hasConcept C27081682 @default.
• W4366988954 hasConcept C2778375690 @default.
• W4366988954 hasConcept C2778715236 @default.
• W4366988954 hasConcept C2779134260 @default.
• W4366988954 hasConcept C2779734285 @default.
• W4366988954 hasConcept C2780304432 @default.
• W4366988954 hasConcept C2780405171 @default.
• W4366988954 hasConcept C42219234 @default.
• W4366988954 hasConcept C44249647 @default.
• W4366988954 hasConcept C67761136 @default.
• W4366988954 hasConcept C71924100 @default.
• W4366988954 hasConceptScore W4366988954C126322002 @default.
• W4366988954 hasConceptScore W4366988954C142724271 @default.
• W4366988954 hasConceptScore W4366988954C187960798 @default.
• W4366988954 hasConceptScore W4366988954C197934379 @default.
• W4366988954 hasConceptScore W4366988954C204787440 @default.
• W4366988954 hasConceptScore W4366988954C27081682 @default.
• W4366988954 hasConceptScore W4366988954C2778375690 @default.
• W4366988954 hasConceptScore W4366988954C2778715236 @default.
• W4366988954 hasConceptScore W4366988954C2779134260 @default.
• W4366988954 hasConceptScore W4366988954C2779734285 @default.
• W4366988954 hasConceptScore W4366988954C2780304432 @default.
• W4366988954 hasConceptScore W4366988954C2780405171 @default.
• W4366988954 hasConceptScore W4366988954C42219234 @default.
• W4366988954 hasConceptScore W4366988954C44249647 @default.
• W4366988954 hasConceptScore W4366988954C67761136 @default.
• W4366988954 hasConceptScore W4366988954C71924100 @default.
• W4366988954 hasFunder F4320332097 @default.
• W4366988954 hasIssue "2" @default.

• next